“Even though prostate cancer patients are anxious to receive treatment, they still want to minimize their exposure to anyone outside their COVID bubble. One procedure that is especially attractive to our patients is focal therapy high intensity focused ultrasound (HIFU). Focal therapy HIFU is appropriate for patients whose prostate cancer is diagnosed at a higher… Read More: An update on prostate cancer treatment [PODCAST] »
MY01, a medtech company based in Montreal, has developed the Continuous Compartment Pressure Monitor, a sterile, single-use device for the diagnosis of acute compartment syndrome. If undiagnosed and untreated, acute compartment syndrome, a condition caused by high pressure around muscles typically following an injury, can have significant consequences for patients. Long-term disability and amputation is… Read More: Diagnosing Acute Compartment Syndrome: Interview with Charles Allan, CEO of… »
Read the Full Article for Free! Read the Full Article for Free! Daily Newsletter Weekly Newsletter (Every Monday) You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access Unlock censored health information that… Read More: Don’t Use Antibody Tests Post Vaccine to Determine Immunity »
FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, June 1, 2021 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with… Read More: FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of… »